Juan Gaztañaga

Antithrombotic effects of factor Xa inhibition with DU-176b: Phase-I study of an oral, direct factor Xa inhibitor using an ex-vivo flow chamber

M. Urooj Zafar, David Vorchheimer, Juan Gaztañaga et al. · Thrombosis and Haemostasis · 2007 · 125 citations

Medicine, Pharmacology, Pharmacotherapy +13

Prognostic Value of Late Gadolinium Enhancement for the Prediction of Cardiovascular Outcomes in Dilated Cardiomyopathy

Ana Carolina Alba, Juan Gaztañaga, Farid Foroutan et al. · Circulation Cardiovascular Imaging · 2020 · 109 citations · Full text

Medicine, Cardiology, Radiology +17

A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome

Juan Gaztañaga, Michael E. Farkouh, James H.F. Rudd et al. · Atherosclerosis · 2015 · 66 citations

Medicine, Cardiology, Pharmacology +17

Usefulness of Cardiac Computed Tomographic Delayed Contrast Enhancement of the Left Atrial Appendage Before Pulmonary Vein Ablation

Simonette T Sawit, Ana García‐Álvarez, Bhavna Suri et al. · The American Journal of Cardiology · 2012 · 56 citations

Medicine, Cardiology, Radiology +13

Right Ventricular Ejection Fraction for the Prediction of Major Adverse Cardiovascular and Heart Failure-Related Events

Yanish Purmah, Lucy Y. Lei, Steven Dykstra et al. · Circulation Cardiovascular Imaging · 2021 · 42 citations · Full text

Medicine, Cardiology, Cardiac Transplantation +15